Bevacizumab

Bevacizumab is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian cancer and cervical cancer.

Bevacizumab is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.

High blood pressure, Protein in urine, Nosebleeds, Exfoliative dermatitis, Decreased white blood cell count (lymphocytes), Low blood platelets, Decreased appetite, Electrolyte imbalance, Peripheral sensory neuropathy, Breathlessness, Thromboembolism, Wound healing complications, Ovarian failure, Mucosal inflammation, Abscess, Cellulitis, Hypersensitivity, Rectovaginal fistula